Current Cardiac arrest News and Events

Current Cardiac arrest News and Events, Cardiac arrest News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Scoring system improves screening for "dual" heart disease
Aortic stenosis is one of the most common heart valve defects. As well as conventional valve replacement involving open-heart surgery, a less invasive procedure has now been available for some time in the form of transcatheter aortic valve replacement (TAVR). (2020-11-24)

Closing the racial disparity gap in survival after in-hospital cardiac arrest
In-hospital cardiac arrests (IHCA) represent catastrophic and often terminal events. Despite investments to improve the quality of resuscitation efforts, fewer than 25% of all patients that experience cardiac arrests in hospitals survive to discharge, and survival varies significantly across hospitals and by race. Until now, few have been able to specify reasons for the between-hospital differences. (2020-11-24)

COVID-19 patients survive in-hospital cardiac arrest at pre-pandemic rates
Resuscitation and survival rates of hospitalized COVID-19 patients who've had cardiac arrest are much higher than earlier reports of near-zero; variation at the individual hospital level may have affected overall numbers (2020-11-20)

A bypass route for the coronary vessels in the heart?
When the heart develops, some of its coronary blood vessels develop from cells lining the inner surface of the heart's ventricular chambers (endocardium). Novel findings suggest that new blood vessel growth in the heart can be stimulated with the VEGF-B growth factor from the same source after myocardial infarction to increase blood delivery to the damaged area. (2020-11-19)

A novel drug target for neonatal and infant heart failure
Researchers have identified a new druggable target for heart failure in neonates and infants. Approximately 60 percent of children born with congenital heart abnormalities will develop overt heart failure within the first year of life. The progression of heart failure in these infants is often rapid, with a high frequency of fatalities. Stimulation of this target significantly increased the cardiac contractility of newborns and infants in mice with few side effects. (2020-11-19)

Implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition
Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries. In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0597, Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, Beijing, China consider implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition of the great arteries. (2020-11-19)

Mediastinal tuberculoma mimicking malignant cardiac tumor
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0587, Yiqian Ding, Wei Li, Yanqiu Liu, Min Ye, Liangping Cheng, Donghong Liu, Hong Lin and Fengjuan Yao from The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China consider mediastinal tuberculoma mimicking malignant cardiac tumors. (2020-11-19)

Early details of brain damage in COVID-19 patients
Looking at six patients using a specialized magnetic resonance technique, researchers at Massachusetts General Hospital found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as other patients who have suffered oxygen deprivation from other causes, but there are also notable differences. (2020-11-18)

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery. When high-risk patients wore a heart monitor 24-hours a day for 30 days after heart surgery, atrial fibrillation was detected ten times more often than in patients who were not monitored continuously. (2020-11-16)

A change of heart -- new drug for HCM reduces heart mass
For the first time, a medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, hypertrophic cardiomyopathy, rather than simply addressing their symptoms. (2020-11-16)

STRENGTH trial finds new fish oil medication did not reduce the risk of cardiac events
A medication derived from fish oil, containing the omega-3 fatty acids EPA and DHA, was evaluated in a large, international study of more than 13,000 people who had existing heart disease or who were at high risk of heart disease due to other medical conditions. The medication did not reduce the risk of cardiac events compared to a corn oil-based placebo in the STRENGTH trial. (2020-11-15)

Omega-3s did not reduce cardiac events in recent heart attack survivors
Omega-3 supplements in commonly available forms appear to be ineffective in preventing further cardiovascular events among elderly people with recent heart attacks. When compared to a placebo, an omega-3 fatty acids supplement in addition to statin therapy and/or a blood thinner did not reduce the number of cardiac events in a study of more than 1,000 patients in Norway. (2020-11-15)

Outcomes for out-of-hospital cardiac arrest during COVID-19 pandemic
This study used a large US registry of out-of-hospital cardiac arrests to asses the association between the COVID-19 pandemic and the outcomes of out-of-hospital cardiac arrests, including in areas with low and moderate COVID-19 disease. (2020-11-14)

Minnesota cardiac arrest resuscitation treatment demonstrated 100% success rate in cannulation
University of Minnesota Minnesota Mobile Resuscitation Consortium proves high survival rates in a peer-reviewed study. (2020-11-13)

Single institution study finds high rates of cardiac complications in MIS-C
During the height of the COVID-19 pandemic, researchers at Children's National Hospital discovered that as many as one half of children diagnosed with multisystem inflammatory disease in children (MIS-C) at the hospital developed cardiac complications including coronary artery abnormalities, even when diagnosed and treated promptly. (2020-11-13)

Remote cardiac rehabilitation programs are effective alternatives to on-site services
Outpatient cardiovascular rehabilitation programs were suspended due to the COVID-19 pandemic, limiting patients' access to these important services. Health care systems in Canada and Japan implemented virtual or remote cardiac rehabilitation programs in response to the public health emergency. These programs were found to be as effective as in-person, outpatient rehabilitation services and could help to increase equitable access and participation rates for cardiac patients. (2020-11-09)

New medication to treat shock caused by blood or fluid loss found safe and effective
Hypovolemic shock, caused by severe loss of blood or body fluids, can be deadly if not treated promptly. Centhaquine is a new medication for the treatment of hypovolemic shock that increases blood flow to the heart and organs to prevent organ failure and death. It is still in clinical trials in the U.S. Results from a small, randomized, placebo-controlled trial in India found that centhaquine significantly improved blood pressure, blood lactate levels and reduced death rate when added to standard treatment. (2020-11-09)

Machine learning helps predict survival rates of out-of-hospital cardiac arrest
Machine learning predictions about the survival rate of an out-of-hospital cardiac arrest were more accurate when neighborhood-level factors were added to the data analysis. Future research can use this newly developed model to identify neighborhood-level intervention methods to decrease death rates from an out-of-hospital cardiac arrest. (2020-11-09)

Acute exposure to higher ozone levels linked to higher risk of cardiac arrest
Analysis of data from 187,000 patients found that higher ozone levels were associated with a higher risk of out-of-hospital cardiac arrest. These findings may have important public health implications for recommendations on ozone regulations from the U.S. Environmental Protection Agency. (2020-11-09)

Serious disparities in care and outcomes found among Black and non-white heart patients
Adults who are Black or from other underrepresented racial/ethnic groups received up to 10% fewer early treatments for heart problems compared to white patients. When compared to whites, Black patients had longer hospital stays and fewer discharges to home. Hispanics, Asians, Pacific Islanders and Native Americans all had higher in-hospital death rates than white patients. (2020-11-09)

Extra precautions during CPR due to the pandemic do not have a negative impact on survival
A U.S. medical center compared outcomes of patients in 2019 and 2020 who had in-hospital cardiopulmonary resuscitation (CPR) to determine if safety precautions due to the pandemic affect patient survival. Researchers analyzed results of COVID-19 patients who had experienced in-hospital CPR and compared them to patients without COVID-19 who had experienced in-hospital CPR and found no significant difference in patient outcomes between the groups. (2020-11-09)

Genetic mutation could worsen heart function in Duchenne muscular dystrophy patients
DALLAS - Nov. 4, 2020 - A mutation in the gene that causes cystic fibrosis may accelerate heart function decline in those with Duchenne muscular dystrophy (DMD), a new study by UT Southwestern researchers suggests. The findings, published online recently in the Journal of the American Heart Association, could help doctors develop new strategies to preserve heart function in this population, potentially extending patients' lives. (2020-11-04)

Implantable device can monitor and treat heart disease
Cunjiang Yu, Bill D. Cook Associate Professor of Mechanical Engineering at UH, led a group of researchers that has reported developing a cardiac patch made from fully rubbery electronics that can be placed directly on the heart to collect electrophysiological activity, temperature, heartbeat and other indicators, all at the same time. (2020-11-03)

Mobile smartphone technology is associated with better clinical outcomes for OHCA
Mobile smartphone technology can accelerate first responder dispatch and may be instrumental to improving out?of?hospital cardiac arrest (OCHA) survival. (2020-10-30)

New strategies suggested for critical heart care in the ICU
Critically ill heart patients are at increased risk of complications that are potentially preventable and associated with death, longer hospital stays and higher costs. Best practices to prevent complications include meticulous hand hygiene among the health care team, prompt removal of invasive medical devices and implementing a multidisciplinary team of health care professionals from various specialties. (2020-10-29)

Cardiac MRI contrast agents carry low risk of adverse events
Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large new study. The findings come three years after the European Union enacted new regulations on the contrast agents. (2020-10-29)

A patch that could help heal broken hearts
According to the American Heart Association, heart disease is the leading cause of death worldwide in recent years. During a heart attack, or myocardial infarction (MI), a blocked artery and the resulting oxygen deprivation cause massive cardiac cell death, blood vessel impairment and inflammation. Now, researchers reporting in ACS Biomaterials Science & Engineering have developed a cardiac patch with tiny engineered blood vessels that improved recovery from MI in rats and pigs. (2020-10-28)

Study reinforces drug's potential to treat hypertrophic cardiomyopathy
WSU research sheds new light on a molecule that may be used to treat heart conditions that can lead to stroke, heart attack and other forms of heart disease. (2020-10-27)

A new playbook: COVID-19, athletes' hearts and return to play
In a special report published in JAMA Cardiology, sports cardiologists offer guidance for athletes' return to play after they have recovered from COVID-19. The article addresses the most common questions posed by the media, in clinics and athletic training rooms, and during discussions among cardiologists who care for athletes. (2020-10-27)

A heart-breast cancer-on-a-chip monitoring system
Dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy. A collaborative team, which includes a group from the Terasaki Institute for Biomedical Innovation, has developed an organs-on-a-chip system that more widely examines the responses of breast cancer and heart tissues to therapeutic breast cancer drugs. (2020-10-26)

High fat or 'ketogenic' diets could prevent, reverse heart failure
Research from Saint Louis University finds that high fat or ''ketogenic'' diets could completely prevent, or even reverse heart failure caused by a metabolic process. The research team, led by Kyle S. McCommis, Ph.D., assistant professor in Biochemistry and Molecular Biology at SLU, looked at a metabolic process that seems to be turned down in failing human hearts. (2020-10-26)

For pregnant women with heart disease, multidisciplinary care may be essential
Cardiovascular disease is the number one cause of maternal mortality in the United States, but a new study suggests specialized cardio-obstetrics teams may improve outcomes. (2020-10-26)

New model predicts which patients with kidney disease may develop heartbeat irregularities
* A new model that incorporates a type of artificial intelligence can accurately predict which individuals with chronic kidney disease face a high risk of developing atrial fibrillation. * Results from the study will be presented online during ASN Kidney Week 2020 Reimagined October 19-October 25. (2020-10-24)

ASTRO: Proton therapy for lung cancer may help reduce risk of heart diseases
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases. (2020-10-23)

MRI safely performed in patients with pacemakers and ICDs
MRI examinations can be performed safely in patients with non-MR compatible cardiac devices, including those who are pacemaker-dependent or have abandoned leads, according to a new study. (2020-10-22)

Updated CPR guidelines tackle health disparities management of opioid-related emergencies and physical, emotional recovery
Updated CPR guidelines address health disparities and the management of opioid-related emergencies as well; early bystander and AED intervention remains key to survival. The Chain of Survival has been expanded to include a recovery link, which emphasizes physical, social, and emotional needs of patients and their caregivers after survivors leave the hospital. CPR training to now include guidance on responding to victims of suspected opioid overdose. (2020-10-21)

Sanctuary policies protect immigrants but don't threaten public safety
Stanford researcher David Hausman analyzed ICE deportations data for 296 large counties combined with FBI crime data. Sanctuary counties experienced a significant decrease in deportations in the months after sanctuary policies were adopted. Deportations of individuals with violent convictions did not decrease, but deportation of individuals without convictions decreased by about half. Sanctuary policies did not have a significant effect on crime rates or the rate at which police arrested individuals for reported crimes. (2020-10-19)

New dimensions in the treatment of muscle spasticity after stroke and nervous system defects
Chronic muscle spasticity after nervous system defects like stroke, traumatic brain and spinal cord injury, multiple sclerosis and painful low back pain affect more than 10% of the population, with a socioeconomic cost of about 500 billion USD. Currently, there is no satisfying remedy to help these suffering people, which generates an immense medical need for a new generation antispastic drug. Drug candidate MPH-220 could mean new hope for millions of patients suffering from spasticity. (2020-10-16)

Results from the FORECAST Trial reported at TCT Connect
In the FORECAST randomized clinical trial, the use of fractional flow reserve management derived from computed tomography (FFRCT) did not significantly reduce costs but did reduce the use of invasive coronary angiography (ICA). (2020-10-16)

Rare congenital heart defect rescued by protease inhibition
A research team at the Greenwood Genetic Center (GGC) has successfully used small molecules to restore normal heart and valve development in an animal model for Mucolipidosis II (ML II), a rare genetic disorder. The study is reported in this month's JCI Insight. (2020-10-15)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.